Concerns Of Severe Side Effects Greatest Barrier To Long-Acting Injectable HIV Prevention Among MSM, Findings Show
July 23, 2021
MedPage Today (7/22, Walker) reports, “Fear of potential severe side effects may be the greatest barrier to long-acting injectable HIV prevention among men who have sex with men (MSM), followed by out-of-pocket costs,” according to findings presented duri...